A NEW DRUG (TYBAMATE) EFFECTIVE IN THE MANAGEMENT OF CHRONIC BRAIN SYNDROME.
D035843:Biomedical Research; D001921:Brain; D001925:Brain Damage, Chronic; D001927:Brain Diseases; D002219:Carbamates; D004358:Drug Therapy; D005853:Geriatrics; D002537:Intracranial Arteriosclerosis; D008620:Meprobamate; D010919:Placebos; D014116:Toxicology; D014149:Tranquilizing Agents
D002219:Carbamates; D010919:Placebos; D014149:Tranquilizing Agents; C100147:tybamate; D008620:Meprobamate
BRAIN DAMAGE, CHRONIC; BRAIN DISEASES; CEREBRAL ARTERIOSCLEROSIS; CLINICAL RESEARCH; DRUG THERAPY; GERIATRICS; MEPROBAMATE; PLACEBOS; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS